Visual hallucinations in older adults are frequently misattributed to psychiatric illness or dementia, causing unnecessary alarm and sometimes inappropriate treatment. A condition called Charles Bonnet Syndrome — where complex, vivid hallucinations arise purely from visual deprivation, not mental illness — turns out to be far more common in ophthalmology waiting rooms than most clinicians expect, and new prospective data sharpen both the prevalence picture and the risk profile.
In a prospective cross-sectional study of 391 patients attending a tertiary cataract assessment clinic, 2.8% met formal diagnostic criteria for Charles Bonnet Syndrome — defined as complex visual hallucinations with retained insight, no causative medication or medical history, and occurring outside hypnagogic or hypnopompic states. An additional 2.1% experienced complex hallucinations exclusively in the sleep-wake transition window. When the analysis was restricted to patients with best-corrected visual acuity worse than 0.3 logMAR in the better-seeing eye, the combined prevalence of complex visual hallucinations jumped to 10%, underscoring that deeper visual impairment is the dominant driver. Multivariable logistic regression confirmed lower binocular visual acuity as a statistically significant independent predictor of CBS. Notably, 27% of CBS-positive patients carried concurrent ocular comorbidities including exudative and drusenoid age-related macular degeneration, suggesting additive retinal pathology amplifies risk beyond lens opacity alone.
Charles Bonnet Syndrome is estimated to affect somewhere between 10% and 40% of patients with significant visual loss across published literature, though figures vary wildly due to inconsistent diagnostic criteria and the well-documented reluctance of patients to self-report hallucinations. This study's relatively conservative 2.8% figure likely reflects a population with milder average visual impairment — cataract patients rather than end-stage retinal disease cohorts — and potentially residual underreporting despite structured screening. The finding that only 6.1% of the full cohort had prior awareness of CBS as a concept highlights a glaring education gap; patients experiencing these hallucinations without explanation often suffer significant psychological distress. The clinical implication is straightforward: structured screening at ophthalmology intake appointments could normalize the experience, reduce psychiatric misreferral, and inform surgical urgency. This is incremental but practically important confirmatory work that strengthens the case for routine CBS screening in any low-vision setting.